Haemonetics Corp. (HAE)
57.39
-0.11
(-0.19%)
USD |
NYSE |
Feb 12, 14:26
Haemonetics Shareholders Equity (Quarterly) : 911.45M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DexCom, Inc. | 2.726B |
| Celldex Therapeutics, Inc. | 598.36M |
| Atossa Therapeutics, Inc. | 49.79M |
| Abeona Therapeutics, Inc. | 171.23M |
| Cell Source, Inc. | -18.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.491B |
| Total Liabilities (Quarterly) | 1.579B |
| Debt to Equity Ratio | 1.344 |
| Current Ratio | 1.748 |
| Net Debt Paydown Yield | 0.00% |